--- title: "Pentosan Polysulfate | PepTracker Pro" description: "A semi-synthetic polysaccharide FDA-approved for interstitial cystitis and studied for joint health applications." lang: en json-ld: | [ { "@context": "https://schema.org", "@type": "Organization", "name": "PepTracker Pro", "url": "https://peptrackerpro.com", "logo": "https://peptrackerpro.com/favicon.png", "description": "Evidence-based educational resource dedicated to improving peptide research literacy.", "contactPoint": { "@type": "ContactPoint", "email": "hello@peptrackerpro.com", "contactType": "customer support" }, "sameAs": [] }, { "@context": "https://schema.org", "@type": "MedicalWebPage", "name": "Pentosan Polysulfate", "description": "A semi-synthetic polysaccharide FDA-approved for interstitial cystitis and studied for joint health applications.", "url": "https://peptrackerpro.com/peptides/pentosan-polysulfate", "lastReviewed": "2026-04-26", "reviewedBy": { "@type": "Organization", "name": "PepTracker Pro Research Team", "url": "https://peptrackerpro.com" }, "isPartOf": { "@type": "WebSite", "name": "PepTracker Pro", "url": "https://peptrackerpro.com" } }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://peptrackerpro.com" }, { "@type": "ListItem", "position": 2, "name": "Peptides", "item": "https://peptrackerpro.com/peptides" }, { "@type": "ListItem", "position": 3, "name": "Pentosan Polysulfate", "item": "https://peptrackerpro.com/peptides/pentosan-polysulfate" } ] }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "People researching joint health therapies?", "acceptedAnswer": { "@type": "Answer", "text": "Pentosan Polysulfate is a research peptide studied in preclinical models. A semi-synthetic polysaccharide FDA-approved for interstitial cystitis and studied for joint health applications." } }, { "@type": "Question", "name": "Those with interstitial cystitis exploring options?", "acceptedAnswer": { "@type": "Answer", "text": "Pentosan Polysulfate is a research peptide studied in preclinical models. A semi-synthetic polysaccharide FDA-approved for interstitial cystitis and studied for joint health applications." } }, { "@type": "Question", "name": "Individuals comparing cartilage-support compounds?", "acceptedAnswer": { "@type": "Answer", "text": "Pentosan Polysulfate is a research peptide studied in preclinical models. A semi-synthetic polysaccharide FDA-approved for interstitial cystitis and studied for joint health applications." } } ] } ] --- [Skip to main content](#main) **Educational information only.** This site does not provide medical advice. [Read full disclaimer](/disclaimer) [PepTracker Pro](/) [Home](/)[Peptides](/peptides)[Compare](/compare)[Glossary](/glossary)[Blog](/blog)[Calculators](/calculators)[Start Here](/start) [Open the App](https://app.peptrackerpro.com) [Peptides](/peptides)/ Pentosan Polysulfate **Research-only content.** This page is for educational purposes and does not constitute medical advice. [Read full disclaimer →](/research-disclaimer) # Pentosan Polysulfate High Evidence A semi-synthetic polysaccharide FDA-approved for interstitial cystitis and studied for joint health applications. Aliases PPS +2 more Evidence High Evidence Last Updated 2026-04-26 Reading Time 3 min ## Table of Contents 1. [What It Is](#what-it-is) 2. [Regulatory Status](#regulatory-status) 3. [Why Researchers Study It](#why-researchers-study) 4. [Proposed Mechanisms](#proposed-mechanisms) 5. [Evidence Snapshot](#evidence-snapshot) 6. [Commonly Discussed Benefits](#benefits) 7. [Safety & Cautions](#safety) 8. [Comparisons](#comparisons) 9. [Calculator Tools](#calculator) 10. [Citations](#citations) ## What It Is Pentosan polysulfate sodium (PPS) is a semi-synthetic heparinoid derived from beechwood hemicellulose. It is FDA-approved under the brand name Elmiron for interstitial cystitis/bladder pain syndrome and is approved as a veterinary joint health product (Zydax/Cartrophen) in several countries including Australia. Research interest has expanded significantly into osteoarthritis, where PPS may act as a disease-modifying therapy rather than simply a symptomatic treatment. A 2026 study published in PLOS One evaluated a six-week PPS course in companion dogs with naturally occurring osteoarthritis, finding sustained clinical, functional, and structural benefits out to 26 weeks. PPS treatment was associated with reductions in serum CTX-I (a bone resorption marker) and hyaluronic acid levels (consistent with reduced inflammatory joint activity), with no adverse events reported throughout the study period. A separate pilot study examined PPS for improving dyslipidaemia and knee pain in people with knee osteoarthritis, and the MaRVeL Phase 2/3 trial is evaluating PPS in symptomatic human knee osteoarthritis with concurrent dyslipidaemia. A 2026 pharmacovigilance analysis of 21 years of FAERS data, published in Frontiers in Medicine, provided post-marketing safety context. The retinal pigmentary maculopathy risk associated with long-term oral Elmiron use (typically years of daily therapy) has led to updated labeling requiring regular ophthalmologic monitoring. PPS for joint health is typically administered as a short course of subcutaneous injections, which carries a different risk profile than chronic oral use for interstitial cystitis. Also known as: PPS, Elmiron, bene-joint ## Regulatory Status FDA-Approved (Interstitial Cystitis) Approved as Elmiron for interstitial cystitis/bladder pain syndrome. Joint health use (subcutaneous) approved in veterinary medicine in several countries. Human OA indication under Phase 2/3 investigation (MaRVeL trial). Effective: 1996 (Elmiron) [View FDA Source](https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020193s014lbl.pdf) ## Why Researchers Study It PPS is unusual among joint health compounds because evidence suggests it may modify osteoarthritis disease progression rather than merely treating symptoms. Its ability to stimulate cartilage matrix synthesis, reduce inflammation, and enhance synovial fluid quality positions it as a potential disease-modifying osteoarthritis drug (DMOAD) — a category with very few candidates. ## Proposed Mechanisms - Stimulates proteoglycan and collagen synthesis in articular cartilage - Enhances hyaluronic acid production in synovial fluid - Inhibits complement activation and reduces inflammatory mediators at joint level - Reduces serum CTX-I (bone resorption marker), suggesting structural disease modification - Demonstrates fibrinolytic and anti-thrombotic properties via heparinoid activity ## Evidence Snapshot High Evidence Low Medium High Study Type Model Outcome Link Animal (canine OA, 2026) Naturally occurring osteoarthritis — 26-week follow-up Sustained clinical, functional, and structural benefits at 6 months; reduced CTX-I and hyaluronic acid; no adverse events [Source](https://pmc.ncbi.nlm.nih.gov/articles/PMC12890089/) Human pilot study Knee osteoarthritis with dyslipidaemia Preliminary evidence of improvement in knee pain scores; further evaluation in Phase 2/3 MaRVeL trial [Source](https://www.sciencedirect.com/science/article/pii/S2665913123000109) Pharmacovigilance (2026) 21-year FAERS database analysis Post-marketing safety profile characterized; retinal maculopathy signal confirmed with chronic oral use [Source](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1811896/full) ## Commonly Discussed Benefits [Joint Health](/benefits/joint-health)[Inflammation](/benefits/inflammation)[Pain Relief](/benefits/pain-relief) Researching Pentosan Polysulfate ? Track it, set reminders, and keep notes in the free app. [Track in App](https://app.peptrackerpro.com/?add=pentosan-polysulfate) ## Safety & Cautions - FDA-approved only for interstitial cystitis (oral); joint health use is off-label in humans - Chronic oral use associated with retinal pigmentary maculopathy — requires ophthalmologic monitoring - Short-course subcutaneous injection (joint health protocol) has a different risk profile than chronic oral therapy - Phase 2/3 human OA trial (MaRVeL) underway but not yet completed - Must be prescribed and monitored by a physician ## Comparisons See how Pentosan Polysulfate compares to related peptides: [Pentosan Polysulfate vs AOD-9604](/compare/pentosan-polysulfate-vs-aod-9604) [Pentosan Polysulfate vs BPC-157](/compare/pentosan-polysulfate-vs-bpc-157) ## Calculator Tools Use our research tools to explore dosing and reconstitution data: [Reconstitution Calculator](/calculators) ## Citations 1. \[1\] Ghosh P. et al. — The role of pentosan polysulfate in articular cartilage repair. Semin Arthritis Rheum. 1999 [PubMed](https://pubmed.ncbi.nlm.nih.gov/10468414/) 2. \[2\] Martinez B. et al. — Effects of PPS on joint structure and function in canine OA. PLOS One. 2026 [PubMed](https://pmc.ncbi.nlm.nih.gov/articles/PMC12890089/) 3. \[3\] MaRVeL Trial — Efficacy and safety of PPS in knee OA with dyslipidaemia. BMC Musculoskelet Disord. 2024 [PubMed](https://pmc.ncbi.nlm.nih.gov/articles/PMC11116866/) 4. \[4\] FAERS Pharmacovigilance — Post-marketing safety of PPS: 21-year analysis. Front Med. 2026 [PubMed](https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1811896/full) ### Keep researching in the app - Log Pentosan Polysulfate to your private tracker - Set a dosing reminder - Compare it side-by-side with your stack [Open PepTracker Pro Free](https://app.peptrackerpro.com/?add=pentosan-polysulfate) [Browse more peptides](/peptides) ## Related Peptides ### AOD-9604 Medium Evidence A modified fragment of human growth hormone studied for fat metabolism without growth-promoting effects. [Fat Loss](/benefits/fat-loss)[Metabolism](/benefits/metabolism)[Joint Health](/benefits/joint-health) [View Details](/peptides/aod-9604) [\+ Compare](/compare?select=aod-9604)[](https://app.peptrackerpro.com/?add=aod-9604) ### BPC-157 Medium Evidence A pentadecapeptide derived from human gastric juice, studied for tissue repair and gut-protective properties. [Recovery](/benefits/recovery)[Gut Health](/benefits/gut-health)[Wound Healing](/benefits/wound-healing)[Joint Health](/benefits/joint-health)+2 more [View Details](/peptides/bpc-157) [\+ Compare](/compare?select=bpc-157)[](https://app.peptrackerpro.com/?add=bpc-157) [PepTracker Pro](/) Educational peptide information and research tracking tools. Not medical advice. #### Explore - [Peptide Directory](/peptides) - [Compare Peptides](/compare) - [Glossary](/glossary) - [Benefits](/benefits/sleep) #### Learn - [Blog](/blog) - [Calculators](/calculators) - [Start Here](/start) - [About](/about) #### Legal - [Editorial Policy](/editorial-policy) - [Research Disclaimer](/research-disclaimer) - [Disclaimer](/disclaimer) - [Privacy Policy](/privacy) - [Terms of Service](/terms) - [Contact](/contact) © 2026 PepTracker Pro. Educational purposes only. Not medical advice. Always consult a licensed healthcare provider.